MARINUS PHARMACEUTICALS, INC. (MRNS) Current State and Local Tax Expense (Benefit) USD 2022 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Marinus Pharmaceuticals, Inc. quarterly Current State and Local Tax Expense (Benefit) history and growth rate from 2022 to 2023.
  • Marinus Pharmaceuticals, Inc. Current State and Local Tax Expense (Benefit) for the quarter ending December 31, 2023 was -$1.54M, a 163% decline year-over-year.
  • Marinus Pharmaceuticals, Inc. Current State and Local Tax Expense (Benefit) for the twelve months ending December 31, 2023 was -$1.54M.
Current State and Local Tax Expense (Benefit), Trailing 12 Months (USD)
Current State and Local Tax Expense (Benefit), Quarterly Data (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 -$1.54M -$3.98M -163% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-05
Q4 2022 $2.45M Jan 1, 2022 Dec 31, 2022 10-K 2024-03-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.